Skip to main content

Table 3 Incidence of adverse dental events during BMA treatment

From: The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service

Adverse dental events

N (%)

Periapical abscess from gingival origin

 

 Without sinus

223 (37.8)

 With sinus

30 (5.1)

Acute periodontitis

175 (29.7)

Acute pericoronitis

88 (14.9)

Medication-related osteonecrosis of jaw

74 (12.5)

Total events

590 (100.0)

  1. BMA, Bone-modifying agent